GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
25 Mar 2025 04:34 PM
RNS
GSK uUTI treatment approved by US FDA
25 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
24 Mar 2025 04:10 PM
RNS
Notice of AGM
24 Mar 2025 07:05 AM
RNS
EMA Filing acceptance for Nucala COPD
24 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
21 Mar 2025 03:30 PM
RNS
Director/PDMR Shareholding
21 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
20 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
19 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
18 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
17 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
14 Mar 2025 03:30 PM
RNS
Director/PDMR Shareholding
14 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
13 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
12 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
11 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
10 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
07 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
06 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
05 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
04 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
03 Mar 2025 05:15 PM
RNS
GSK plc 2024 Annual Report on Form 20-F
03 Mar 2025 03:00 PM
RNS
Total Voting Rights
03 Mar 2025 07:05 AM
RNS
US FDA accept 2 depemokimab indication submissions
03 Mar 2025 07:00 AM
RNS
ANCHOR results presented at 2025 AAAAI
03 Mar 2025 07:00 AM
RNS
Transaction in Own Shares
28 Feb 2025 07:00 AM
RNS
Transaction in Own Shares
27 Feb 2025 10:00 AM
RNS
GSK publishes Annual Report 2024
27 Feb 2025 07:00 AM
RNS
Transaction in Own Shares
26 Feb 2025 04:00 PM
RNS
Director/PDMR Shareholding
26 Feb 2025 07:00 AM
RNS
Transaction in Own Shares
25 Feb 2025 07:00 AM
RNS
Transaction in Own Shares
24 Feb 2025 07:05 AM
RNS
GSK completes acquisition of IDRx, Inc.
24 Feb 2025 07:00 AM
RNS
GSK plc commences share buyback programme
21 Feb 2025 07:00 AM
RNS
Directorate Change
21 Feb 2025 07:00 AM
RNS
Director/PDMR Shareholding
21 Feb 2025 07:00 AM
RNS
Director/PDMR Shareholding
21 Feb 2025 07:00 AM
RNS
Director/PDMR Shareholding
21 Feb 2025 07:00 AM
RNS
Director/PDMR Shareholding
21 Feb 2025 07:00 AM
RNS
Director/PDMR Shareholding
21 Feb 2025 07:00 AM
RNS
Director/PDMR Shareholding
20 Feb 2025 07:00 AM
RNS
Nucala COPD submission accepted in China
17 Feb 2025 07:00 AM
RNS
GSK 5-in-1 meningitis vaccine approved by US FDA
13 Feb 2025 03:30 PM
RNS
Director/PDMR Shareholding
11 Feb 2025 03:30 PM
RNS
Director/PDMR Shareholding
05 Feb 2025 07:00 AM
RNS
Final Results
03 Feb 2025 04:48 PM
RNS
Total Voting Rights
28 Jan 2025 07:05 AM
RNS
Depemokimab dual filing in China and Japan
28 Jan 2025 07:00 AM
RNS
EMA accepts two submissions for depemokimab

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100